Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma Meeting Abstract
| Authors: | Wang, Y.; Larson, M. C.; Kumar, A.; Hill, B. T.; Bond, D. A.; Kahl, B. S.; Danilov, A. V.; Merryman, R.; Grover, N. S.; Tun, A. M.; Ayyappan, S. R.; Pongas, G.; Portell, C. A.; Munoz, J.; Reagan, P. M.; Moustafa, M. A.; Pophali, P. A.; Greenwell, I. B.; Cohen, J. B.; Martin, P. |
| Abstract Title: | Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401656 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.7006 |
| Notes: | Meeting Abstract: 7006 -- Source: Wos |
